Related references
Note: Only part of the references are listed.Phase 1 trial of ralimetinib (LY2228820) with radiotherapy plus concomitant temozolomide in the treatment of newly diagnosed glioblastoma
J. Biau et al.
RADIOTHERAPY AND ONCOLOGY (2021)
Safety and efficacy of combination therapy using programmed cell death protein-1/programmed cell death ligand-1 inhibitors and radiotherapy in patients with non-small-cell lung cancer: A systematic review and meta-analysis
Yichao Geng et al.
CANCER MEDICINE (2021)
Comparison of Oncologic Outcomes between Carbon Ion Radiotherapy and Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer
Yuhei Miyasaka et al.
CANCERS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
MiR-130a Acts as a Tumor Suppressor MicroRNA in Cutaneous Squamous Cell Carcinoma and Regulates the Activity of the BMP/SMAD Pathway by Suppressing ACVR1
Warangkana Lohcharoenkal et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)
miR-130a-Mediated KLF3 Can Inhibit the Growth of Lung Cancer Cells
Ming-Chao Wei et al.
CANCER MANAGEMENT AND RESEARCH (2021)
A randomized, double-blind, placebo-controlled phase 1b/2 study of ralimetinib, a p38 MAPK inhibitor, plus gemcitabine and carboplatin versus gemcitabine and carboplatin for women with recurrent platinum-sensitive ovarian cancer
Ignace Vergote et al.
GYNECOLOGIC ONCOLOGY (2020)
MicroRNA-130a enhances the killing ability of natural killer cells against non-small cell lung cancer cells by targeting signal transducers and activators of transcription
Xiaohu Zhou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
The p38 Pathway: From Biology to Cancer Therapy
Adrian Martinez-Limon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Y Chromosome LncRNA Are Involved in Radiation Response of Male Non-Small Cell Lung Cancer Cells
Tayvia Brownmiller et al.
CANCER RESEARCH (2020)
Non-Coding RNAs in Cancer Radiosensitivity: MicroRNAs and lncRNAs as Regulators of Radiation-Induced Signaling Pathways
Marta Podralska et al.
CANCERS (2020)
Radiotherapy treatment for lung cancer: Current status and future directions
Shalini K. Vinod et al.
RESPIROLOGY (2020)
The therapeutic potential of exosomal miR-22 for cervical cancer radiotherapy
Hiromi Konishi et al.
CANCER BIOLOGY & THERAPY (2020)
Integrated analysis of circRNA-miRNA-mRNA network reveals potential prognostic biomarkers for radiotherapies with X-rays and carbon ions in non-small cell lung cancer
Xiaodong Jin et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Upregulation of miR-675-5p induced by lncRNA H19 was associated with tumor progression and development by targeting tumor suppressor p53 in non-small cell lung cancer
Zi-Hui Zheng et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Hypofractionated carbon-ion radiotherapy for stage I peripheral nonsmall cell lung cancer (GUNMA0701): Prospective phase II study
Jun-ichi Saitoh et al.
CANCER MEDICINE (2019)
Long Noncoding RNA CRNDE/PRC2 Participated in the Radiotherapy Resistance of Human Lung Adenocarcinoma Through Targeting p21 Expression
Ming Zhang et al.
ONCOLOGY RESEARCH (2018)
Expression and role of long non-coding RNA H19 in carcinogenesis
Hisashi Yoshimura et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2018)
Expression level of long noncoding RNA H19 in plasma of patients with nonsmall cell lung cancer and its clinical significance
Jianhua Luo et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2018)
The LncRNA H19/miR-193a-3p axis modifies the radio-resistance and chemotherapeutic tolerance of hepatocellular carcinoma cells by targeting PSEN1
Hongbin Ma et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Long non-coding RNA PVT1 predicts poor prognosis and induces radioresistance by regulating DNA repair and cell apoptosis in nasopharyngeal carcinoma
Yi He et al.
CELL DEATH & DISEASE (2018)
Long noncoding RNA CASC9.5 promotes the proliferation and metastasis of lung adenocarcinoma
Jianlong Zhou et al.
SCIENTIFIC REPORTS (2018)
Predictive relevance of ncRNAs in non-small-cell lung cancer patients with radiotherapy: a review of the published data
Qian Huang
BIOMARKERS IN MEDICINE (2018)
Association between H19 SNP rs217727 and lung cancer risk in a Chinese population: a case control study
Lingling Li et al.
BMC MEDICAL GENETICS (2018)
Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma
Anita G. Seto et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Lung cancer: current therapies and new targeted treatments
Fred R. Hirsch et al.
LANCET (2017)
Carbon-ion radiotherapy for non-small cell lung cancer with interstitial lung disease: a retrospective analysis
Mio Nakajima et al.
RADIATION ONCOLOGY (2017)
p38γ and p38δ: From Spectators to Key Physiological Players
Ana Cuenda et al.
TRENDS IN BIOCHEMICAL SCIENCES (2017)
A phase 1/2a, dose-escalation, safety, pharmacokinetic, and preliminary efficacy study of intraperitoneal administration of BC-819 (H19-DTA) in subjects with recurrent ovarian/peritoneal cancer
Ofer Lavie et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2017)
A First-in-Human Phase I Study of the Oral p38 MAPK Inhibitor, Ralimetinib (LY2228820 Dimesylate), in Patients with Advanced Cancer
Amita Patnaik et al.
CLINICAL CANCER RESEARCH (2016)
Single-Fraction Carbon-Ion Radiation Therapy for Patients 80 Years of Age and Older With Stage I Non-Small Cell Lung Cancer
Masataka Karube et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer
Glen Reid et al.
EPIGENOMICS (2016)
Evidence-based Estimates of the Demand for Radiotherapy
G. P. Delaney et al.
CLINICAL ONCOLOGY (2015)
NON-CODING RNA Towards a molecular understanding of microRNA-mediated gene silencing
Stefanie Jonas et al.
NATURE REVIEWS GENETICS (2015)
DNA Based Therapy with Diphtheria Toxin-A BC-819: A Phase 2b Marker Lesion Trial in Patients with Intermediate Risk Nonmuscle Invasive Bladder Cancer
Ofer N. Gofrit et al.
JOURNAL OF UROLOGY (2014)
Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer
N. Hanna et al.
CANCER GENE THERAPY (2012)
Discovering the first microRNA-targeted drug
Morten Lindow et al.
JOURNAL OF CELL BIOLOGY (2012)
With-No-Lysine Kinase 3 (WNK3) stimulates glioma invasion by regulating cell volume
Brian R. Haas et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2011)
The functional role of long non-coding RNA in human carcinomas
Ewan A. Gibb et al.
MOLECULAR CANCER (2011)
ATR-dependent activation of p38 MAP kinase is responsible for apoptotic cell death in cells depleted of Cdc7
Jun-Sub Im et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Protein kinase WNK3 increases cell survival in a caspase-3-dependent pathway
F. Verissimo et al.
ONCOGENE (2006)
Share Paper
